Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Endourol ; 26(1): 32-7, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21905846

RESUMEN

BACKGROUND AND PURPOSE: Staphylococcus saprophyticus is a frequent cause of both uncomplicated and complicated urinary tract infections (UTI) in young females and has recently been established as the most prominent gram-positive uropathogen. Although the effects of subinhibitory concentrations of antimicrobials on numerous other pathogenic bacteria have been studied, little is known regarding how S saprophyticus responds under such conditions. MATERIALS AND METHODS: In this study, we investigated the effects of subminimum inhibitory concentrations (MIC) of ciprofloxacin (CIP) on S saprophyticus attachment to glass microscope slides, ureteral stent material, and T24 bladder cells, as well as its effects on S saprophyticus-induced proinflammatory cytokine expression in bladder cells. RESULTS: Adherence to glass microscope slides, ureteral stent material, and bladder cell monolayers were all significantly increased in the presence of sub-MIC levels of CIP. While the S saprophyticus challenge of T24 bladder cell monolayers significantly upregulated both interleukin (IL)-6 and IL-8 expression, sub-MIC CIP abrogated these effects, returning their secretion to control levels. CONCLUSIONS: Our results demonstrate that exposure to sub-MIC CIP increases S saprophyticus adherence to both abiotic and biotic surfaces including urinary device material and cultured bladder cells. In addition, low levels of this antimicrobial downregulate S saprophyticus-stimulated proinflammatory cytokine secretion in the bladder. These changes may make S saprophyticus more effective at colonizing the urinary tract and highlights the need for clinicians to consider the impact of subinhibitory concentrations of antimicrobials on bacteria when designing treatment strategies to manage UTI.


Asunto(s)
Adhesión Bacteriana/efectos de los fármacos , Ciprofloxacina/farmacología , Ciprofloxacina/uso terapéutico , Staphylococcus saprophyticus/efectos de los fármacos , Staphylococcus saprophyticus/patogenicidad , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Línea Celular , Citocinas/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Mediadores de Inflamación/metabolismo , Pruebas de Sensibilidad Microbiana , Staphylococcus saprophyticus/ultraestructura , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/microbiología , Virulencia/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA